Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Delaware Healthcare Fund

+ Add to Watchlist

DLHIX:US

20.53 USD 0.15 0.74%

As of 09:29:30 ET on 03/27/2015.

Snapshot for Delaware Healthcare Fund (DLHIX)

Year To Date: +7.32% 3-Month: +6.26% 3-Year: +24.24% 52-Week Range: 16.57 - 20.99
1-Month: +1.63% 1-Year: +18.80% 5-Year: +20.33% Beta vs RGUSH: 0.91

Mutual Fund Chart for DLHIX

No chart data available.
  • DLHIX:US 20.53
  • 1M
  • 1Y
Interactive DLHIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DLHIX

Delaware Healthcare Fund is an open-end fund incorporated in the USA. The Fund's objective is to maximize long-term capital growth through capital appreciation. The Fund invests at least 80% of its assets in the equity securities of health care companies.

Inception Date: 09-28-2007 Telephone: 1-800-523-1918
Managers: LIU-ER CHEN "NU"
Web Site: www.delawareinvestments.com/co/delaware

Fundamentals for DLHIX

NAV (on 2015-03-27) 20.53
Assets (M) (on 2015-03-27) 482.68
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for DLHIX

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-12-05) 0.06
Dividend Yield (ttm) 10.39

Fees & Expenses for DLHIX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 1.10

Top Fund Holdings for DLHIX

Filing Date: 01/30/2015
Name Position Value % of Total
Eli Lilly & Co 550,000 39,600,000 8.704%
Sanofi 300,000 27,639,526 6.075%
Teva Pharmaceutical Industries 450,000 25,587,000 5.624%
Bristol-Myers Squibb Co 341,737 20,596,489 4.527%
UCB SA 249,785 19,416,259 4.267%
Chugai Pharmaceutical Co Ltd 600,000 17,940,592 3.943%
GlaxoSmithKline PLC 400,000 17,600,000 3.868%
Quest Diagnostics Inc 220,000 15,635,400 3.437%
Boston Scientific Corp 970,000 14,365,700 3.157%
SINA Corp/China 385,000 13,944,700 3.065%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil